CCC Live Cases > COVID > P2Y12 Inhibitor Monotherapy after PCI: The TWILIGHT Study and Recent Lancet Meta-Analysis

P2Y12 Inhibitor Monotherapy after PCI: The TWILIGHT Study and Recent Lancet Meta-Analysis

Moderator: Roxana Mehran, MD

Samin Sharma, MD
Annapoorna Kini, MD
George Dangas, MD
Usman Baber, MD
Giulio Stefanini, MD
Mauro Chiarito, MD
Valentin Fuster, MD

1:03:05

Comments

Leave a Reply

Your email address will not be published.*